Yayın:
Desloratadine-Eudragit<sup>®</sup> RS100 Nanoparticles: Formulation and Characterization

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAKYIL, EVRİM
dc.contributor.orcid0000-0002-7979-0089
dc.date.accessioned2025-11-13T10:09:55Z
dc.date.issued2017-07-25
dc.identifier.doihttps://doi.org/10.4274/tjps.52523
dc.identifier.endpage156
dc.identifier.issn1304-530X
dc.identifier.issue2
dc.identifier.openalexW2737690470
dc.identifier.startpage148
dc.identifier.urihttps://hdl.handle.net/11421/3322
dc.identifier.urihttps://doi.org/10.4274/tjps.52523
dc.identifier.volume14
dc.language.isoen
dc.relation.ispartofTurkish Journal of Pharmaceutical Sciences
dc.rightsopenAccess
dc.subjectDesloratadine
dc.subjectNanoparticle
dc.subjectCharacterization (materials science)
dc.subjectNuclear chemistry
dc.subjectChemistry
dc.subjectMaterials science
dc.subjectPharmacology
dc.subjectNanotechnology
dc.subjectMedicine
dc.titleDesloratadine-Eudragit<sup>®</sup> RS100 Nanoparticles: Formulation and Characterization
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5039882624

Dosyalar

Koleksiyonlar

Publications